Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

2021/12/23 by Elisabetta Cameroni, John E. Bowen, Laura E. Rosen +53 · 2 citations
Medicine · #SARS-CoV-2 and COVID-19 Research #COVID-19 Clinical Research Studies #SARS-CoV-2 detection and testing

paper · pdf · doi:10.1038/d41586-021-03825-4

openalex publication_date 2021/12/23 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01

Citations

• MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability
• Spike mutation D614G alters SARS-CoV-2 fitness
• The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and in vivo activity against SARS-CoV-2
• Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
• Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization

Cited by

• The Remarkable Evolutionary Plasticity of Coronaviruses by Mutation and Recombination: Insights for the COVID-19 Pandemic and the Future Evolutionary Paths of SARS-CoV-2
• SARS-CoV-2 Omicron variant [wikipedia]